
Featured
Vistagen's Fasedienol Nasal Spray Shows Promise in Phase 2 Trial for Severe Social Anxiety
Vistagen Therapeutics reported positive Phase 2 topline results for its repeat-dose fasedienol nasal spray, showing nominally significant reductions i...
Read Full Story →